| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4050008 | Clinical Biomechanics | 2016 | 10 Pages |
•Only one prospective study has determined the in vivo ACL biomechanical risk factors.•Knee abduction angles and moments were risk factors for female athletes.•Most studies present weaker associative and retrospective evidence.•Conflict was evident in associative and retrospective studies.
BackgroundWhilst many studies measure large numbers of biomechanical parameters and associate these to anterior cruciate ligament injury risk, they cannot be considered as anterior cruciate ligament injury risk factors without evidence from prospective studies. A review was conducted to systematically assess the in vivo biomechanical literature to identify biomechanical risk factors for non-contact anterior cruciate ligament injury during dynamic sports tasks; and to critically evaluate the research trends from retrospective and associative studies investigating non-contact anterior cruciate ligament injury risk.MethodsAn electronic literature search was undertaken on studies examining in vivo biomechanical risk factors associated with non-contact anterior cruciate ligament injury. The relevant studies were assessed by classification; level 1 — a prospective cohort study, level 2 — a retrospective study or level 3 — an associative study.FindingsAn initial search revealed 812 studies but this was reduced to 1 level 1 evidence study, 20 level 2 evidence studies and 175 level 3 evidence studies that met all inclusion criteria. Level 1 evidence showed that the knee abduction angle, knee abduction moment and ground reaction force were biomechanical risk factors. Nine level 2 studies and eighty-three level 3 studies used these to assess risk factors in their study. Inconsistencies in results and methods were observed in level 2 and 3 studies.InterpretationThere is a lack of high quality, prospective level 1 evidence related to biomechanical risk factors for non-contact anterior cruciate ligament injury. More prospective cohort studies are required to determine risk factors and provide improved prognostic capability.
